U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

Results: 1 to 20 of 25

Tests names and labsConditionsGenes, analytes, and microbesMethods

Invitae Expanded Renal Disease Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
693388
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

NR3C2 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoNeuro Panel

Centogene AG - the Rare Disease Company
Germany
18861858
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Intellectual Disability Panel

Centogene AG - the Rare Disease Company
Germany
777770
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CentoNephro Panel

Centogene AG - the Rare Disease Company
Germany
498498
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoNephro Plus Panel

Centogene AG - the Rare Disease Company
Germany
499499
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CentoICU Panel

Centogene AG - the Rare Disease Company
Germany
829848
  • C Sequence analysis of the entire coding region

Invitae Renal Tubular Disorders Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
6839
  • D Deletion/duplication analysis

Pseudohypoaldosteronism type I, autosomal dominant, 177735, Autosomal dominant (Renal pseudohypoaldosteronism type 1) (NR3C2 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

RenalZoom

Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine
United States
525338
  • C Sequence analysis of the entire coding region

Pseudohypoaldosteronism Type I Panel

PreventionGenetics, part of Exact Sciences
United States
24
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Autosomal Dominant Pseudohypoaldosteronism Type 1 via the NR3C2 Gene

PreventionGenetics, part of Exact Sciences
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Pseudohypoaldosterolism panel. NGS panel of 10 genes.

Genologica Medica
Spain
1510
  • C Sequence analysis of the entire coding region

Monogenic Hypertension Genetic Panel

MNG Laboratories (Medical Neurogenetics, LLC.)
United States
1611
  • C Sequence analysis of the entire coding region

Bartter Syndrome

Asper Biogene Asper Biogene LLC
Estonia
3524
  • C Sequence analysis of the entire coding region

Bartter Syndrome NGS Panel

Fulgent Genetics
United States
3927
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

PSEUDOHYPOALDOSTERONISM, RENAL, TYPE 1 (AUTOSOMAL DOMINANT)

Laboratorio de Genetica Clinica SL
Spain
11
  • C Sequence analysis of the entire coding region

Pseudohypoaldosteronism type 1, autosomal dominant

Bioarray
Spain
11
  • C Sequence analysis of the entire coding region

Pseudohypoaldosteronism Panel

CeGaT GmbH
Germany
79
  • C Sequence analysis of the entire coding region

NR3C2 Single Gene

Fulgent Genetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 25

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.